3,174 Shares in DocuSign, Inc. (NASDAQ:DOCU) Acquired by Frank Rimerman Advisors LLC

Frank Rimerman Advisors LLC bought a new position in DocuSign, Inc. (NASDAQ:DOCU) during the 4th quarter, Holdings Channel reports. The institutional investor bought 3,174 shares of the company’s stock, valued at approximately $285,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in DOCU. Amundi boosted its holdings in DocuSign by 565.8% in the fourth quarter. Amundi now owns 1,379,575 shares of the company’s stock worth $123,486,000 after purchasing an additional 1,172,368 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in DocuSign by 61.5% in the fourth quarter. Bank of New York Mellon Corp now owns 1,673,612 shares of the company’s stock worth $150,525,000 after purchasing an additional 637,505 shares during the last quarter. Fiera Capital Corp purchased a new stake in DocuSign in the fourth quarter worth approximately $47,920,000. Principal Financial Group Inc. boosted its holdings in DocuSign by 3,026.7% in the fourth quarter. Principal Financial Group Inc. now owns 546,796 shares of the company’s stock worth $49,179,000 after purchasing an additional 529,308 shares during the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec boosted its holdings in DocuSign by 42.4% in the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,459,580 shares of the company’s stock worth $90,625,000 after purchasing an additional 434,312 shares during the last quarter. Hedge funds and other institutional investors own 77.64% of the company’s stock.

Insider Buying and Selling at DocuSign

In other DocuSign news, CEO Allan C. Thygesen sold 40,000 shares of DocuSign stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $90.04, for a total value of $3,601,600.00. Following the sale, the chief executive officer now directly owns 156,050 shares in the company, valued at approximately $14,050,742. The trade was a 20.40 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Teresa Briggs sold 534 shares of DocuSign stock in a transaction on Monday, March 17th. The shares were sold at an average price of $87.41, for a total transaction of $46,676.94. Following the completion of the sale, the director now owns 8,270 shares in the company, valued at approximately $722,880.70. This represents a 6.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 96,422 shares of company stock worth $8,903,395. Insiders own 1.66% of the company’s stock.

DocuSign Stock Performance

DOCU opened at $83.43 on Tuesday. DocuSign, Inc. has a fifty-two week low of $48.70 and a fifty-two week high of $107.86. The firm’s fifty day moving average is $87.82 and its 200 day moving average is $79.69. The stock has a market cap of $16.85 billion, a price-to-earnings ratio of 17.20, a price-to-earnings-growth ratio of 6.94 and a beta of 1.02.

DocuSign (NASDAQ:DOCU) last announced its quarterly earnings results on Thursday, March 13th. The company reported $0.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.84 by $0.02. The company had revenue of $776.25 million for the quarter, compared to the consensus estimate of $760.94 million. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. DocuSign’s revenue for the quarter was up 9.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.76 EPS. On average, equities research analysts predict that DocuSign, Inc. will post 1.17 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. Jefferies Financial Group raised their target price on shares of DocuSign from $80.00 to $95.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. JMP Securities reiterated a “market outperform” rating and set a $124.00 price target on shares of DocuSign in a research note on Tuesday, January 7th. Morgan Stanley lifted their price target on shares of DocuSign from $62.00 to $97.00 and gave the stock an “equal weight” rating in a research note on Friday, December 6th. JPMorgan Chase & Co. upgraded shares of DocuSign from an “underweight” rating to a “neutral” rating and lifted their price target for the stock from $70.00 to $75.00 in a research note on Monday, March 10th. Finally, UBS Group dropped their price target on shares of DocuSign from $100.00 to $90.00 and set a “neutral” rating on the stock in a research note on Friday. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $95.58.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.